PFS
GBT

Prospera Financial Services’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Prospera Financial Services’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,633
Closed -$90K – 1679
2020
Q3 		$90K Buy
+1,633
New +$104K 0.03% 435

Other funds holding GBT

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Prospera Financial Services's GBT Position: Q4 2020 in Review

Prospera Financial Services sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2020, closing a stake of 1,633 shares — an estimated $90K sold.

Prospera Financial Services first reported a position in GBT in Q3 2020 and held it in 1 quarter. The position peaked at $90K in Q3 2020. 228 funds tracked by Wall St. Rank hold GBT as of Q4 2020.

  • Prospera Financial Services reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Prospera Financial Services sold 1,633 Global Blood Therapeutics, Inc. shares in Q4 2020, an estimated $90K.
  • Prospera Financial Services first reported a position in Global Blood Therapeutics, Inc. in Q3 2020 and held it in 1 quarter.
  • Prospera Financial Services's Global Blood Therapeutics, Inc. position peaked at $90K in Q3 2020.
  • 228 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2020.

Based on Prospera Financial Services's 13F filing for Q4 2020, filed 12 Feb 2021.